Mannatech (NASDAQ:MTEX) Stock Price Passes Below 200-Day Moving Average – Should You Sell?

Shares of Mannatech, Incorporated (NASDAQ:MTEXGet Free Report) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $6.47 and traded as low as $5.00. Mannatech shares last traded at $5.17, with a volume of 4,559 shares changing hands.

Analysts Set New Price Targets

Separately, Weiss Ratings cut shares of Mannatech from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, June 11th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has an average rating of “Sell”.

Get Our Latest Research Report on MTEX

Mannatech Stock Up 2.0%

The firm has a 50 day simple moving average of $5.08 and a two-hundred day simple moving average of $6.47. The company has a market capitalization of $9.98 million, a PE ratio of -0.77 and a beta of 0.71. The company has a current ratio of 1.09, a quick ratio of 0.59 and a debt-to-equity ratio of 0.48.

Mannatech (NASDAQ:MTEXGet Free Report) last released its earnings results on Thursday, May 14th. The company reported $0.49 earnings per share (EPS) for the quarter. Mannatech had a negative return on equity of 2,383.34% and a negative net margin of 11.97%.The business had revenue of $24.92 million for the quarter.

Insiders Place Their Bets

In other news, Director Kevin Andrew Robbins acquired 7,100 shares of the company’s stock in a transaction on Tuesday, May 19th. The shares were bought at an average cost of $4.17 per share, with a total value of $29,607.00. Following the purchase, the director owned 33,333 shares of the company’s stock, valued at $138,998.61. This represents a 27.07% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In the last 90 days, insiders have acquired 14,903 shares of company stock valued at $62,155. Company insiders own 41.50% of the company’s stock.

About Mannatech

(Get Free Report)

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.

Featured Articles

Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.